SCR-LIP-000621 · Claim · machine-readable JSON →
Pain reduction in lipedema may not be mediated by changes in systemic inflammatory or fibrotic markers.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- high (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema — Lundanes et al. (2025) ✓ verified — consistent · rct · 2025 · reading confidence: moderate
“NÃO houve associação significativa entre mudanças em dor e mudanças em hsCRP, citocinas, marcadores fibróticos ou cetose (βHB) na semana 9, tanto na análise ITT quanto PP”
In a randomised low-carbohydrate vs low-fat diet trial, pain changes at week 9 were not associated with changes in hsCRP, cytokines, fibrotic markers or ketosis, in ITT or PP analyses.
This is an RCT directly measuring inflammatory cytokines, fibrosis markers, and pain in lipedema patients, providing evidence that systemic inflammation does not explain pain mechanisms in lipedema, thereby refining the understanding of the
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000008